Group 1: Core Announcement - The company announced the expected daily related transactions for 2026, which were approved by the board with a unanimous vote [1][28] - The independent directors confirmed that the expected transactions are within the normal business operations and do not harm the interests of the company or its shareholders [1][28] Group 2: Related Party Transactions - The expected daily related transactions for 2026 include procurement of materials from Guangzhou Shimei Packaging Industrial Co., Ltd. and sales of products to Unoquip GmbH [7][8] - The transactions with Shimei Packaging are based on market prices and are governed by a procurement framework contract effective for 12 months [7][8] - The transactions with Unoquip GmbH will be priced based on historical sales margins and market conditions [8] Group 3: Financial Data of Related Parties - Shimei Packaging has total assets of 9.0841 million RMB and net assets of 8.5298 million RMB as of December 31, 2025, with a revenue of 28.9089 million RMB and a net profit of 0.8801 million RMB [3] - Unoquip GmbH has total assets of 9.5010 million Swiss Francs and a net asset deficit of 5.3380 million Swiss Francs as of December 31, 2025, with a revenue of 6.6850 million Swiss Francs and a net loss of 1.9590 million Swiss Francs [5] Group 4: Cash Management - The company plans to use up to 350 million RMB of idle funds for cash management, which was approved by the board [12][18] - The cash management will involve low-risk financial products and will not affect the company's main business operations [13][22] - The investment period for the financial products will not exceed 12 months [17]
广州维力医疗器械股份有限公司关于2026年度日常关联交易预计的公告